New drug to protect infants from RSV receives FDA approval

shutterstock_232416201935012

The Food and Drug Administration (“FD”) announced Monday it has approved a drug by which newborns and infants can be protected against respiratory syncytial virus (“RSV”) for an entire season with a single shot. The RSV virus